Skip to main content

ACTELION PHARMACEUTICALS AUSTRALIA PTY. LIMITED

ABN cancelledABN cancelled from 19 Jul 2021

Australian private company · last location NSW 2113

ABN cancelled
ABN
32 097 278 512Cancelled from 19 Jul 2021
GST
CancelledFrom 18 May 2021
Last location
NSW 2113Main business location

Registration

Legal name
ACTELION PHARMACEUTICALS AUSTRALIA PTY. LIMITED
ABN
32 097 278 512 Cancelled from 19 Jul 2021
Entity type
Australian Private Company
GST
Cancelled from 18 May 2021
DGR
Not endorsed
Last main business location
NSW 2113
Former and other names (1)
  • ACTELION PHARMACEUTICALS AUST PTY LTDTrading name (ABR; not updated by the ABR since 2012)

Trade marks, patents and designs (215)

Trade marks 86

Trade markStatusFiled
Image markNo. 2622730 · Classes 5, 44Protected29 Jan 2026
NUELPHINo. 2607441 · Class 5Protected27 Nov 2025
ELVUZONo. 2605264 · Class 5Protected20 Nov 2025
BEXAPHYNo. 2605256 · Class 5Protected20 Nov 2025
PHUMANNo. 2147770 · Classes 9, 41, 44Protected7 Jan 2021
Image markNo. 2095476 · Classes 9, 16, 42, 44Protected12 Jun 2020
ECHORIGHTNo. 2074076 · Classes 9, 41Protected6 Mar 2020
SUSPECT PHNo. 2042380 · Classes 41, 42, 44Protected9 Oct 2019
PHEDERATIONNo. 2041767 · Classes 9, 35, 42, 44Protected4 Oct 2019
Image markNo. 1945130 · Class 5Protected1 Aug 2018
VIVLANYNo. 1928886 · Class 5Protected24 May 2018
VEVLANYNo. 1928885 · Class 5Protected24 May 2018
OCYNTIONo. 1928884 · Class 5Protected24 May 2018
YUVANCINo. 1876308 · Class 5Protected28 Sep 2017
OPSYNVINo. 1874626 · Class 5Protected21 Sep 2017
GOVANTYNo. 1840689 · Class 5Protected27 Apr 2017
ORISVIONo. 1840688 · Class 5Protected27 Apr 2017
EDVANCINo. 1840675 · Class 5Protected27 Apr 2017
GOVANCINo. 1839399 · Class 5Protected20 Apr 2017
CDI-DAYSYMSNo. 1822262 · Classes 9, 16, 42, 44Protected26 Jan 2017
UPTRAVINo. 1677209 · Classes 5, 16, 44Protected26 Feb 2015
EVIVICONo. 1660833 · Class 5Protected27 Nov 2014
EVIVORYNo. 1652661 · Class 5Protected16 Oct 2014
HDISS-DUNo. 1557302 · Classes 9, 16, 42, 44Protected16 May 2013
FSIQ-RMSNo. 1557295 · Classes 9, 16, 42, 44Protected16 May 2013
PAH-SYMPACTNo. 1550904 · Classes 9, 16, 42, 44Protected11 Apr 2013
Image markNo. 1542006 · Class 5Protected21 Feb 2013
OPSUMITNo. 1542004 · Class 5Protected21 Feb 2013
Image markNo. 1529723 · Class 5Protected6 Dec 2012
OPSUMITNo. 1440493 · Class 5Protected4 Aug 2011
UPTRAVINo. 1440434 · Class 5Protected4 Aug 2011
Image markNo. 1406722 · Class 5Protected3 Feb 2011
ZAVESCANo. 1406721 · Class 5Protected3 Feb 2011
ACTELIONNo. 1358333 · Classes 3, 5, 10, 16, 44Protected29 Apr 2010
ZEPENDONo. 1357295 · Class 5Protected22 Apr 2010
ZAVESCANo. 1346118 · Class 5Protected18 Feb 2010
BRAZAVESNo. 1342467 · Class 5Protected28 Jan 2010
REEOVEERNo. 1332009 · Class 5Protected19 Nov 2009
STAYVEERNo. 1332008 · Class 5Protected19 Nov 2009
CARIPULNo. 1245670 · Class 5Protected12 Jun 2008
RESTANANo. 1226597 · Class 5Protected28 Feb 2008
TARLEVONo. 1210153 · Class 5Protected15 Nov 2007
ACTELION TRAXNo. 1105999 · Classes 9, 38, 42Protected30 Mar 2006
Image markNo. 1096602 · Class 5Protected2 Feb 2006
VELETRINo. 882811 · Class 5Protected16 Jul 2001
TRACLEERNo. 859811 · Class 5Protected7 Dec 2000
No longer current (40)
Trade markStatusFiled
PH ConnectNo. 2034555 · Classes 41, 42, 44Lapsed28 May 20213 Sep 2019
PH HUBNo. 2029948 · Classes 9, 41, 44Lapsed28 May 202114 Aug 2019
ACTELIONNo. 1750029 · Classes 5, 42, 44Ceased18 Dec 20254 Feb 2016
Image markNo. 1748734 · Classes 3, 5, 9, 10, 16, 35, 36, 38, …Ceased17 Dec 202528 Jan 2016
PAHUMANNo. 1660810 · Classes 16, 41, 44Ceased29 Oct 202427 Nov 2014
ONFORVANo. 1652663 · Class 5Ceased22 Sep 202416 Oct 2014
ONFORSINo. 1652662 · Class 5Ceased22 Sep 202416 Oct 2014
BATLADIFNo. 1652660 · Class 5Ceased22 Sep 202416 Oct 2014
PAHUMANNo. 1628044 · Classes 16, 41, 44Ceased16 Apr 202412 Jun 2014
CDAD-DAYSYMSNo. 1605624 · Classes 9, 16, 42, 44Ceased3 Jan 202413 Feb 2014
NOILETCAPHARMNo. 1488615 · Classes 1, 5, 44Ceased22 Mar 20223 May 2012
MARKLASNo. 1484896 · Classes 1, 5, 44Ceased7 Mar 202212 Apr 2012
PAGADIMNo. 1440503 · Class 5Ceased27 Jun 20214 Aug 2011
ERFLOVONo. 1440495 · Class 5Ceased27 Jun 20214 Aug 2011
NUFLOZIANo. 1440494 · Class 5Ceased27 Jun 20214 Aug 2011
EVIGUSNo. 1440492 · Class 5Ceased27 Jun 20214 Aug 2011
STORGAZONo. 1440491 · Class 5Ceased27 Jun 20214 Aug 2011
SUMZOTINo. 1440487 · Class 5Ceased27 Jun 20214 Aug 2011
TAVLEEDNo. 1440486 · Class 5Ceased27 Jun 20214 Aug 2011
ZUXTANANo. 1440485 · Class 5Ceased27 Jun 20214 Aug 2011
LONVOGANo. 1440484 · Class 5Ceased27 Jun 20214 Aug 2011
ALISPEERNo. 1440438 · Class 5Ceased27 Jun 20214 Aug 2011
TURLEBONo. 1440437 · Class 5Ceased27 Jun 20214 Aug 2011
ERAGOLTNo. 1440436 · Class 5Ceased27 Jun 20214 Aug 2011
RYCORZNo. 1440435 · Class 5Ceased27 Jun 20214 Aug 2011
SONFIDINo. 1440433 · Class 5Ceased27 Jun 20214 Aug 2011
CONFORXYNo. 1383469 · Class 5Ceased17 Aug 202016 Sep 2010
ZEPENDESNo. 1342466 · Class 5Ceased16 Dec 201928 Jan 2010
LISUNARNo. 1245671 · Class 5Ceased13 May 201812 Jun 2008
VELETRINo. 1096605 · Class 5Ceased15 Dec 20152 Feb 2006
VELETRINo. 1096604 · Class 5Ceased15 Dec 20152 Feb 2006
Image markNo. 1096601 · Class 5Ceased14 Dec 20252 Feb 2006
ACTELIONNo. 1091737 · Class 5Ceased16 Aug 202522 Dec 2005
Image markNo. 1036228 · Class 5Ceased29 Dec 201429 Dec 2004
PAHNo. 1036227 · Class 5Ceased29 Dec 201429 Dec 2004
ERAJETNo. 882810 · Class 5Ceased16 Jul 201116 Jul 2001
KRYSOFNo. 841524 · Class 5Ceased5 Jul 20105 Jul 2000
KIPLIVNo. 841523 · Class 5Ceased5 Jul 20105 Jul 2000
KIPLITNo. 841522 · Class 5Ceased5 Jul 20105 Jul 2000
ACTELION CREATIVE SCIENCE FOR ADVANCED MEDICINESNo. 776052 · Classes 3, 5Ceased19 Oct 201819 Oct 1998

Patents 129

TitleStatusFiled
Pharmaceutical composition for the treatment of pulmonary arterial hypertensionNo. 2019410727Granted19 Jul 2021
Therapeutic compositions containing macitentanNo. 2009280843Granted7 Mar 2011
Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitorNo. 2007290099Granted23 Mar 2009
Stable pharmaceutical composition comprising a pyrimidine-sulfamideNo. 2006290309Granted4 Apr 2008
Novel sulfamides and their use as endothelin receptor antagonistsNo. 2002227984Granted1 May 2003
No longer current (124)
TitleStatusFiled
PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORSNo. 2022317287Lapsed16 Jul 20264 Jan 2024
PROCESS FOR MANUFACTURING A DIPHENYLPYRAZINE DERIVATIVENo. 2022214283Lapsed15 Jan 202620 Jul 2023
PHARMACEUTICAL COMPOSITION COMPRISING A DIPHENYLPYRAZINE DERIVATIVENo. 2022214282Lapsed15 Jan 202620 Jul 2023
PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORSNo. 2021405620Lapsed11 Dec 20258 Jun 2023
Methods of slowing brain volume lossNo. 2021232637Lapsed21 Feb 202524 Aug 2022
Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in Fontan-palliated patientsNo. 2020393489Lapsed14 Nov 202424 Jun 2022
Methods of treating pulmonary arterial hypertensionNo. 2020392424Lapsed14 Nov 202410 May 2022
Pharmaceutical composition comprising selexipagNo. 2020369912Lapsed6 May 202629 Mar 2022
Methods of treating multiple sclerosisNo. 2020316640Lapsed4 Feb 20268 Feb 2022
Macitentan for use in treating portopulmonary hypertensionNo. 2020252263Lapsed17 Oct 20253 Nov 2021
Pharmaceutical composition comprising macitentan for the treatment of chronic thromboembolic pulmonary hypertensionNo. 2020211014Lapsed11 Jan 202423 Aug 2021
Dosing regimen for a selective S1P1 receptor agonistNo. 2020202684Lapsed25 Jun 202222 Apr 2020
Pharmaceutical composition comprising selexipagNo. 2018229750Lapsed29 Feb 202420 Aug 2019
NADPH oxidase 4 inhibitorsNo. 2016284942Ceased4 Jan 202416 Nov 2017
PROCESS FOR MANUFACTURING PYRIMIDINE SULFAMIDE DERIVATIVESNo. 2017202446Ceased27 Aug 202512 Apr 2017
Tricyclic piperidine compoundsNo. 2014352008Ceased1 Jun 202315 Jun 2016
Quinolone derivativesNo. 2014261101Lapsed24 Feb 201725 Nov 2015
Orexin receptor antagonists which are ortho bi hetero-aryl-2-meta bi hetero-aryl-pyrrolidin-1-yl-methanone derivativesNo. 2013328301Lapsed3 Nov 20168 May 2015
Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulatorsNo. 2012356076Lapsed30 Mar 201618 Jul 2014
Quinazoline-24-dione derivativesNo. 2012293329Lapsed14 Jan 20167 Mar 2014
Heterocyclic amide derivatives as P2X7 receptor antagonistsNo. 2012288511Lapsed7 Jan 201621 Feb 2014
3-ureidoisoquinolin-8-yl derivativesNo. 2012235706Lapsed26 Nov 201525 Oct 2013
Combinations comprising macitentan for the treatment of glioblastoma multiformeNo. 2012213036Lapsed17 Aug 20163 Sep 2013
Hydroxylated aminotriazole derivatives as ALX receptor agonistsNo. 2011340103Lapsed20 Jun 20164 Jul 2013
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulatorsNo. 2011275417Lapsed19 Jun 20151 Feb 2013
Antibacterial isoquinolin-3-ylurea derivativesNo. 2011234010Lapsed14 Oct 201529 Oct 2012
Bridged spiro 24 heptane derivatives as ALX receptor and/or FPRL2 agonistsNo. 2010250789Ceased1 Dec 201615 Dec 2011
Thiazole derivatives and their use as P2Y12 receptor antagonistsNo. 2010240527Lapsed4 Nov 201414 Nov 2011
6-3-aza-bicyclo310hex-3-yl-2-phenyl-pyrimidines as ADP receptor antagonistsNo. 2010233378Lapsed21 Oct 20144 Nov 2011
Phenethylamide derivatives and their heterocyclic analoguesNo. 2009305005Lapsed28 Apr 201410 May 2011
Oxazolidinyl antibioticsNo. 2009302007Ceased23 Apr 20184 May 2011
Tricyclic alkylaminomethyloxazolidinone derivativesNo. 2009278791Lapsed10 Jan 201328 Feb 2011
Tetrahydroisoquinolines as antimalarial agentsNo. 2009250843Lapsed5 May 201216 Dec 2010
5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseasesNo. 2009245351Ceased22 Nov 20246 Dec 2010
Benzimidazole derivatives as calcium channel blockersNo. 2009239620Lapsed5 May 201224 Nov 2010
2-phenyl-4-cyclopropyl-pyrimidine derivativesNo. 2009235123Lapsed18 Apr 201210 Nov 2010
Substituted 2-phenyl-pyridine derivativesNo. 2009235033Lapsed23 Oct 201410 Nov 2010
Novel aminomethyl benzene derivativesNo. 2009220893Lapsed18 Apr 20126 Oct 2010
Oxazolidinone derivativesNo. 2009215247Ceased5 Sep 201621 Sep 2010
2-aza-bicyclo221heptane derivativesNo. 2009215243Lapsed2 Sep 201320 Sep 2010
Azatricyclic antibiotic compoundsNo. 2009215327Lapsed4 Apr 201217 Sep 2010
Combination comprising paclitaxel for treating ovarian cancerNo. 2009215329Ceased2 Sep 201613 Sep 2010
5-aminocyclylmethyl-oxazolidin-2-one derivativesNo. 2008337096Ceased1 Jul 201614 Jul 2010
Thiophene derivatives as agonists of S1P1/EDG1No. 2008334297Lapsed22 Mar 20122 Jul 2010
Novel pyrimidine derivativesNo. 2008320374Lapsed9 Mar 201228 May 2010
Pyridine derivatives as S1P1/EDG1 receptor modulatorsNo. 2008290233Ceased2 Mar 201515 Mar 2010
12-diamido-ethylene derivatives as orexin antagonistsNo. 2008288151Lapsed28 Feb 201412 Mar 2010
2-aza-bicyclo330octane derivativesNo. 2008281399Lapsed11 Feb 201422 Feb 2010
3-aza-bicyclo330octane compoundsNo. 2008272449Lapsed16 Jan 20142 Feb 2010
Thiazolidine derivatives as orexin receptor antagonistsNo. 2008231441Lapsed18 Nov 201119 Oct 2009

Showing the 50 most recent of 124 patents.

Current means registered, granted or still being examined. Applications are listed by filing date, newest first.

History

  1. 19 Jul 2021
    ABN cancelledABR
  2. 18 May 2021
    GST registration cancelledABR

We record changes every week from 20 Nov 2026. Earlier dates come from each register.

Related

Also in postcode 2113

All businesses in postcode 2113 →